Medications
Compounded semaglutide, Ozempic, Wegovy
Monthly Cost
Starting as low as $127/mo
Speed to Start
Moderate
Est. 2020
About Midi Health
Midi Health occupies a unique and clinically important niche in the GLP-1 telehealth landscape: it is built specifically for women in menopause and perimenopause. Founded in 2020, Midi offers both compounded and brand-name GLP-1 medications (including Ozempic and Wegovy) starting from $127 per month, but what sets it apart is the integration of weight-management treatment with comprehensive hormone-aware clinical care.
The clinical model at Midi Health is among the most thorough we have evaluated. Patients receive care from providers who specialize in menopause medicine and understand how fluctuating estrogen, progesterone, and other hormones directly affect metabolism, weight distribution, and GLP-1 medication response. The platform includes lab testing, registered dietitian access, and ongoing clinical monitoring as part of its care plans. This is not a prescription mill; it is a multidisciplinary care team approach that treats weight as one component of a larger hormonal health picture.
Third-party validation is strong. Midi holds a 4.0-star rating across 1,220+ reviews on Trustpilot and a B rating with the Better Business Bureau. Patient reviews consistently highlight the quality of provider interactions, the depth of the initial evaluation, and the relief of finding a platform that understands menopause-related weight gain. Negative reviews occasionally mention wait times for initial appointments and insurance billing complexity.
Midi Health also accepts insurance, which is a meaningful differentiator. Many telehealth GLP-1 platforms operate on a cash-pay-only basis, but Midi’s insurance integration can dramatically reduce out-of-pocket costs for eligible patients. Combined with the option to prescribe either brand-name or compounded medications, Midi gives providers the flexibility to match treatment to each patient’s clinical needs and financial situation.
Our editorial team considers Midi Health a category leader for its target population. For women experiencing menopause or perimenopause who are struggling with weight changes, Midi offers a level of clinical specificity, hormonal expertise, and wraparound support that generic telehealth platforms simply cannot match. The combination of lab testing, dietitian access, hormone-aware prescribing, and insurance acceptance makes it one of the most comprehensive GLP-1 programs available.
At a Glance
Medications Offered
Compounded semaglutide, Ozempic, Wegovy
Both
Cost & Insurance
- Monthly: Starting as low as $127/mo
- 6-month estimate: $900-$2,100
- Insurance: Yes
- Self-pay: Yes
Clinical Features
- Lab testing: Yes
- Dietitian access: Yes
- Verified Pharmacy: Not disclosed for compounded; also offers brand-name Ozempic/Wegovy
- BBB Rating: B
Delivery & Access
- Format: Subcutaneous
- Nationwide telehealth: Yes
- Speed: Moderate
- Spanish-speaking providers: Not available
Medical Disclaimer: This review is for informational purposes only and does not constitute medical advice. GLP-1 medications are prescription drugs that should only be used under the supervision of a licensed healthcare provider. Individual results may vary.
Editorial Independence: GLP-1.Reviews maintains full editorial independence. Our scores are based on verified data and standardized criteria.
What the Midi Health Intake Looks Like
Midi Health is a midlife women’s health specialist clinic — menopause and perimenopause care is the primary framing, with weight management offered as one of several visit reasons. The public intake we walked through at joinmidi.com is a six-screen appointment booking flow, not a clinical questionnaire. A patient picks a visit reason, creates an account, confirms contact information, decides on insurance or self-pay, and puts a card on file to book. The actual clinical assessment — including anything GLP-1-specific — happens during the live video visit with a Midi clinician.
Very low on the public intake — by design. Midi’s booking funnel does not ask a single clinical question: no BMI calculator, no medical history, no medications list, no allergies, no FDA black-box family-history screen, no mental-health instrument, no substance use, no eating-disorder check, no pregnancy status. The score reflects pre-visit safety gating only, not the quality of Midi’s underlying clinical care — all of that work is deferred to the live video visit with a specialist clinician, which is legitimate traditional telemedicine but not something we can assess from the booking flow alone.
Low. Six screens and roughly two minutes to book the first visit. The card-on-file screen explicitly states “You won’t pay anything now. We will only charge your card after you’ve completed a visit” — no subscription, no auto-renew, no pre-selected multi-month bundle, no countdown timers. The main friction is the $250 first-visit fee (subsequent visits $150) and the hard Medicare/Medicaid exclusion, which cannot be worked around on the public funnel.
The 5 Stages
On the visit-reason screen, the Weight Management tile explicitly lists the options as “GLP-1s, HRT, and lifestyle counseling.” That framing is meaningful for women in perimenopause or menopause who are dealing with weight gain that is tangled up with hormonal changes, sleep disruption, and mood shifts — Midi treats weight as one thread in a larger midlife-health picture rather than as a standalone prescription transaction. A patient who wants to talk to a clinician about whether a GLP-1 fits alongside HRT and other menopause care, rather than being put on a GLP-1 in isolation, is the core audience Midi is built for.
The card-on-file screen shows $250 for the first visit and $150 for subsequent visits directly above the card form. There is no monthly subscription, no pre-selected multi-month prepay plan, no discount framing, and no countdown timer. “Due today: $0” is shown in the footer alongside the “Save Credit Card” button, and the page copy confirms the card is only charged after a visit has actually been completed. That is the opposite of the subscription-commerce default that dominates the compounded-GLP-1 shopping funnels.
Midi’s model is traditional specialist telemedicine: the patient books a visit with a midlife-health clinician, the visit happens by video, and the clinical history, safety screening, and prescribing decisions all happen during that conversation. For a patient interested in a GLP-1 prescription, the FDA black-box family-history questions, the pregnancy and breastfeeding status check, the eating-disorder screen, the pancreatitis and thyroid-cancer history, and the mental-health review are all asked by the clinician during the visit rather than on a pre-committed online questionnaire. That is arguably a stronger safety model than reading a long written form with no follow-up clarification — the clinician can ask clarifying questions in real time — but it also means the $250 first-visit fee is committed before the clinician has seen any information.
The insurance-choice screen surfaces a hard restriction: “Midi does not currently accept Medicare, Medicaid, or Medi-Cal.” The notice clarifies that Medicare patients may self-pay the $250 first-visit / $150 subsequent-visit rate, but Medicaid and Medi-Cal patients cannot use Midi’s services at all — even on a self-pay basis. For a midlife-health clinic where many patients are of Medicare age (65+), this is a real coverage limitation worth knowing before investing the time in registration. Patients on traditional Medicare or on Medicaid/Medi-Cal should verify whether the out-of-pocket rate is workable — or whether they need to find a provider who is in-network with their specific plan.
The public booking flow does not ask a BMI or eligibility-gating weight question, does not collect a medical history, does not ask about current medications or allergies, does not include a dedicated MEN-2 or medullary thyroid cancer family-history screen, does not ask the eating-disorder question, does not check pregnancy or breastfeeding status, does not include a validated mental-health instrument, and does not ask about substance or alcohol use. Every one of those questions is deferred to the live video visit with the Midi clinician. A patient who wants to be prepared for the first visit should come ready to discuss their full medical history verbally, including any family history of thyroid cancer or MEN-2, any history of pancreatitis or eating disorders, any current mental-health care, and any medications or allergies.
Source: GLP-1.Reviews editorial walkthrough on April 15, 2026. We completed every screen of the public Midi Health booking flow at joinmidi.com and stopped before authorizing the card-on-file for the $250 first visit.
Opens joinmidi.com in a new tab. We may earn a commission if you start treatment through this link, at no additional cost to you.
